Bioluminescence Imaging

The objective of this project is to develop new visualisation techniques for bioluminescence imaging.

Description

In the past decade, molecular imaging has quickly evolved as an important medical imaging tool, especially for small-animal imaging. Using the different molecular imaging modalities that are available today, such as MRI, various types of optical imaging, PET, SPECT and ultrasound, body processes can be monitored at the molecular level in-vivo. Each of these imaging modalities having their specific properties, combining multiple modalities is becoming very important in increasing the amount of information that can be obtained from them. This is the point where advanced data visualization techniques come into play. The goal of our project is to develop visualization techniques that make full use of the available data to significantly increase the amount of information that can be obtained from it and thus allow for more insight into the data.

The main characteristic of molecular imaging techniques is that they are aimed at imaging certain targets or target processes. Probes, also called biomarkers, can be developed to signal at the presence of a target or at a certain event, such as the activation of a specific gene (gene expression), cell division or cell death. The research area aimed at developing such probes is a subject in itself and we will not focus on this.

Particular attention has been given to the optical imaging techniques called bioluminescence imaging and fluorescence imaging, where optical light that is emitted by certain markers is captured using a sensitive CCD camera. The main difference between the two techniques is that fluorescence imaging uses an external light source to excite the probe/marker, where for bioluminescence imaging the light is naturally emitted by cells that have been genetically altered with DNA of, for example, fireflies. The advantage of fluorescence imaging is that the light source location, wavelength and intensity (on/off) can be controlled, and with this extra information it is easier to determine the depth of the signal. On the other hand, the signal-to-noise-ratio in fluorescence imaging is lower than in bioluminescence imaging, because of autofluorescence.

xenogen_scanner_small.png

Figure 1 - The IVIS 3D BLI scanner from Xenogen. (http://www.xenogen.com)

For our project, and for clarity, we will focus on a specific case study: a mouse that has been injected with a certain form of cancer cells that emit a bioluminescent signal. This enables us to track the location and size of the tumor, which information is used by biologists to test the effectiveness of a certain treatment. The mouse has been imaged with a 3D BLI scanner as shown in figure 1. In this scanner, the mouse, which has been anesthetized, is put on a tray that rotates around a mirror. In this way a number of images can be taken from different angles, in this case four. Subsequently, the mouse is scanned in a micro-CT scanner. This procedure is repeated after a number of weeks in order to track the tumor growth and metastasis.

optical_and_bli.png

Figure 2 - A traditional overlay of a BLI signal on a photograph. The data in this image and those below has been acquired by the Department of Endocrinology (Courtesy of Clemens Lowik), Leiden University Medical Center

In the traditional way, using the software that comes with the BLI-scanner, the BLI signal is visualized by applying a color map to the BLI-signal and overlaying this on a normal photograph of the mouse (figure 2). This gives the biologist a global idea of where the tumor is located and of its size. However, the 2D view is not ideal in that it doesn't contain any spatial or structural information, which is the reason that we want to combine the data with a 3D structural modality, in this case a CT-scan.

To integrate the information in all these scans, we have to overcome a number of challenges:

rd_reconstruction.png

Figure 3 - The BLI signal is back projected into a volume.

bli_ct_overlay.png

Figure 4 - Overlay of BLI data on a CT scan.

bli_ct_volumes_small.png

Figure 5 - BLI data isosurfaces combined with a CT scan volume rendering.

posture0_small.png

posture1_small.png

posture2_small.png

Figure 6 - Posture and physiology change over time, which makes accurate comparison difficult.

The Cyttron Visualization Platform

We are implementing the resulting algorithms of all the challenges listed above into a platform called the Cyttron Visualization Platform (CVP). We are developing this platform as a part of Cyttron (http://www.cyttron.org). The Cyttron consortium is a collaboration between a number of companies and universities, which perform various types of projects. The main aim is to integrate data from resolutions that range from the cellular to the molecular level (this is mainly microscopy data). The idea is to create a tool that can be used to determine the cause of diseases at the molecular level and use this for diagnosis and therapy development.

The fact that the CVP is aimed at integrating multiple modalities makes it perfect for our purpose. Also, the CVP has been designed to be easily extendible, so we have implemented a large part of the work directly into the CVP. Currently, we have a plugin that allows the user to walk through a wizard-like interface, processing the BLI- and CT-data step by step. Because this platform is meant to be used by biologists, they can instantly make use of our algorithms. More information on the CVP can be found on the Cyttron Visualization Platform website.

Media

Projects/BioluminescenceImaging (last edited 2010-06-21 14:53:16 by localhost)